MET in ovarian cancer: Metastasis and resistance?

Autor Tang, Chad, Jardim, Denis L, Hong, David
Vydáno 2014

Recent results of immunotherapy and perspectives for advanced NSCLC

Autor Jardim, Denis L, de Melo Gagliato, Debora
Vydáno v Lung Cancer Manag (2016)

Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

Autor Jardim, Denis L Fontes, Conley, Anthony, Subbiah, Vivek
Vydáno 2013

Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA—clinical utility, current limitations and future perspectives

Autor de Melo Gagliato, Debora, Fontes Jardim, Denis L.
Vydáno v Ann Transl Med (2018)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology

Autor Jardim, Denis L., de Melo Gagliato, Débora, Kurzrock, Razelle
Vydáno v Integr Cancer Ther (2018)

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker

Autor Jardim, Denis L., Goodman, Aaron, Gagliato, Debora de Melo, Kurzrock, Razelle
Vydáno v Cancer Cell (2020)

Analysis of Drug Development Paradigms for Immune Checkpoint inhibitors

Autor Jardim, Denis L., de Melo Gagliato, Débora, Giles, Francis J., Kurzrock, Razelle
Vydáno v Clin Cancer Res (2017)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis

Autor Ikeda, Sadakatsu, Schwaederle, Maria, Mohindra, Mandakini, Fontes Jardim, Denis L., Kurzrock, Razelle
Vydáno v J Hematol Oncol (2018)

Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds

Autor Jardim, Denis L., De Melo Gagliato, Débora, Nikanjam, Mina, Barkauskas, Donald A., Kurzrock, Razelle
Vydáno v Oncoimmunology (2020)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer

Autor Knebel, Franciele H., Bettoni, Fabiana, da Fonseca, Leonardo G., Camargo, Anamaria A., Sabbaga, Jorge, Jardim, Denis L.
Vydáno v Front Oncol (2019)

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions

Autor Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Vydáno v Oncologist (2020)

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

Autor Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Vydáno v Oncologist (2021)

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities

Autor Millis, Sherri Z., Jardim, Denis L., Albacker, Lee, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Kurzrock, Razelle
Vydáno v Cancer (2018)

Use of expansion cohorts in phase 1 trials and probability of success in phase 2 for 381 anticancer drugs

Autor Bugano, Diogo D. G., Hess, Kenneth, Jardim, Denis L. F., Zer, Alona, Meric-Bernstam, Funda, Siu, Lillian L., Razak, Albiruni, Hong, David S.
Vydáno v Clin Cancer Res (2017)

Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval

Autor Fontes Jardim, Denis L., Schwaederle, Maria, Wei, Caimiao, Lee, J. Jack, Hong, David S., Eggermont, Alexander M., Schilsky, Richard L., Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Vydáno v J Natl Cancer Inst (2015)

FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors

Autor Jardim, Denis L., Wheler, Jennifer J., Hess, Kenneth, Tsimberidou, Apostolia M., Zinner, Ralph, Janku, Filip, Subbiah, Vivek, Naing, Aung, Piha-Paul, Sarina A., Westin, Shannon N., Roy-Chowdhuri, Sinchita, Meric-Bernstam, Funda, Hong, David S.
Vydáno 2014

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

Autor Tang, Chad, Fontes Jardim, Denis L., Falchook, Gerald S., Hess, Kenneth, Fu, Siqing, Wheler, Jennifer J., Zinner, Ralph G., Naing, Aung, Tsimberidou, Apostolia M., De Melo Galgiato, Debora, Westin, Shannon N., Meric-Bernstam, Funda, Kurzrock, Razelle, Hong, David S.
Vydáno v Oncoscience (2013)

SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review

Autor Haradaa, Guilherme, Antonacio, Fernanda F, Gongora, Aline BL, Behar, Marina H, Capareli, Fernanda C, Bastos, Diogo A, Munhoz, Rodrigo R, Costa, Frederico P, Jardim, Denis L, Arrais-Rodrigues, Celso, Novis, Yana, Katz, Artur, de Castro Junior, Gilberto
Vydáno v Ecancermedicalscience (2020)

Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit

Autor de Melo Gagliato, Debora, Fontes Jardim, Denis L., Falchook, Gerald, Tang, Chad, Zinner, Ralph, Wheler, Jennifer J., Janku, Filip, Subbiah, Vivek, Piha-Paul, Sarina A., Fu, Siqing, Hess, Kenneth, Roy-Chowdhuri, Sinchita, Moulder, Stacy, Gonzalez-Angulo, Ana M., Meric-Bernstam, Funda, Hong, David S.
Vydáno v Clin Breast Cancer (2014)

MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors

Autor Jardim, Denis L. F., de Melo Gagliato, Débora, Falchook, Gerald, Zinner, Ralph, Wheler, Jennifer J., Janku, Filip, Subbiah, Vivek, Piha-Paul, Sarina A., Fu, Siqing, Tannir, Nizar, Corn, Paul, Tang, Chad, Hess, Kenneth, Roy-Chowdhuri, Sinchita, Kurzrock, Razelle, Meric-Bernstam, Funda, Hong, David S.
Vydáno v Clin Genitourin Cancer (2014)